Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Keysight Technologies Inc (KEYS) vs Tempus AI (TEM) Price & Performance

Keysight Technologies IncTrade

Price performance (Past 24H)

Key statistics

Keysight Technologies Inc vs Tempus AI — how do they compare? Keysight Technologies Inc trades at $342.01 (market cap $57.32B), while Tempus AI trades at $54.7 (market cap $9.93B). The key difference: Keysight Technologies Inc is far larger — about 5.8× Tempus AI's market cap, and Keysight Technologies Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.

KEYSTEM
Market Cap
$57.32B$9.93B
Sector
TechnologyBroad Market / Factor
52-Week High
$373.34$103.25
52-Week Low
$158.51$41.55
Enterprise Value
$57.67B$10.56B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Keysight Technologies Inc

Keysight Technologies (KEYS) trades at $340.97, up 1.19% today, near its 52-week high. The stock shows strong momentum with bullish moving averages and consistent earnings beats, including Q1 2026 EPS of $2.87 versus $2.32 expected. Revenue for 2025 reached $5.38B with a net income margin of 17.31%. Recent news highlights product innovations like the APS-ONE-400 cybersecurity platform and collaborations with Intel and the European Space Agency, reinforcing growth prospects in 5G and defense markets.

Outlook remains positive with a consensus price target of $396.56, implying 16% upside, supported by 81% analyst buy ratings. Risks include elevated valuation multiples (P/E 54.91) and high RSI levels suggesting overbought conditions. Investors should monitor execution on 2026 revenue guidance of $6.1B and manage exposure to tech sector volatility.

Tempus AI

Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.

Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.

Returns comparison

Trailing returns across standard periods

About Keysight Technologies Inc

Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.

Read more on KEYS

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM